Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Opko Health, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Opko Health, Inc.

Regulatory records
1
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 1 FDA record to the applicant name Opko Health, Inc.. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Jul 25, 2025 to Jul 25, 2025. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code QRF appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P190022, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 4400 Biscayne Blvd., Miami, FL, 33137. Recorded on P190022/S003, decision dated Jul 25, 2025.

Changes described in PMA records

P190022/S003: 4Kscore Test

FDA’s recorded scope: Approval for the addition of the DRE Unavailable variant as part of the 4KScore Test system

Jul 25, 2025 · Normal 180 Day Track

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

  1. 4Kscore Test

    P190022/S003 · PMA supplement
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.